Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1998-07-21
2000-07-04
Ambrose, Michael G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514316, 514318, 514326, 544295, 544360, 544364, 544372, 546187, 546188, 546193, 546208, 546210, A61K 31495
Patent
active
060839503
ABSTRACT:
Novel piperzine derivatives substituted on one nitrogen by an aromatic system and on the other nitrogen by (2,5-dioxopyrrolidin)-1-yl) alkanes or (2,6-dioxopiperidin-1-yl) alkanes have been found to exhibit selective .alpha..sub.1A adrenergic activity. The compounds are useful for treatment of disease conditions, such as peripheral vascular disease, congestive heart failure, hypertension and especially benign prostatic hypertrophy.
REFERENCES:
patent: 4479954 (1984-10-01), Hirose et al.
patent: 4524206 (1985-06-01), New et al.
patent: 5859014 (1999-01-01), Bantle et al.
Chilmonczyk, Zdzislaw, et., "Conformational Flexibity of Serotonin1 A Receptor Ligands form Crystallographic Data. Updated Model of the Receptor Pharmacophore", Chemical Abstracts 127:234308, vol. 127, No. 17 (1997).
DiMoglo, A.S. et al., "Study of Structure-Activity Relations in a Series of Buspirone Analogs Using an Electron-Topological Approach", Chemical Abstracts 129:22916, vol. 129, No. 3 (1998).
Hays, Sheryl J., "Synthesis of Carbon-14 Labeled CI-926 and CI-927, New Antihypertensives,"Chemical Abstracts 108:21844 vol. 108, No. 3 (1988).
Ishizumi, Kikuo et al., "Synthesis and Anxiolytic Activity of N-Substituted Cyclic Imides (1R.sup..star-solid.,2S.sup..star-solid.,3R.sup..star-solid.,4S.sup..star- solid.)-N-[4-[4-(2-Pyrimidinyl)-1-Piperazinyl]Butyl]-2,3-Bicyclo[2.2.1]Hept anedicar-Boximide (Tandospirone) and Related Compounds", Chem. Pharm,.Bull., vol. 39, No. 9 (1991) pp. 2288-2300.
Khadilkar, B.M. et al., "Synthesis and Pharmacology of Some2-[3-(4-Aryl-1-Piperaxinyl)-Propyl]-1H-Benz[DE]Isoquinolin-1,3(2H)-Dio nes", Chemical Abstracts107:198046, vol. 107:198046, vol. 107, No. 21 (1987).
Khandilkar, B.M., et al., "Synthesis and Hypotensive Activity of Some Succinimide Derivatives", Chemical Abstracts 119:27951, vol. 119, No. 3 (1993).
Ryan, M.J., et al., "CI-926 (3-[4-[4-(3-Methylphenyl)-1-Piperazinyl]Butyl]-2,4-Imidazolinedione): Antihypertensive Profile and Pharmacology", Chemical Abstracts 105:164679, vol. 105, No. 19 (1986).
Wu, Yao-Hua, et al., "Psychosedative Agents. N-(4-Phenyl-1-Piperazinylalkyl)-Substituted Cyclic Imides", J. Med. Chem., vol. 12 (1969) pp. 876-881.
Database CAPLUS on STN International.RTM., Chemical Abstracts Service, (Columbus, Ohio), Accession No. 1983:46453; Yevich et al. J. Med. Chem. (1983), 26(2), 194-203, abstract.
Database CAPLUS on STN International.RTM., Chemical Abstracts Service, (Columbus, Ohio), Accession No. 1997:687574; Mokrosz et al. Arch. Pharm. (Weinheim, Germany) (1997). 330(6), 177-180, abstract, Oct. 1997.
Barry Kenny et al., "Pharmaceutical Options," -J. Med. Chem., 23, pp. 1293-1315 (Apr. 1997).
S.D. Sament, et al., "N-(N.sup.4 -Ary-N.sup.1 piperazinylmethyl) . . . , " J. Indian Chec. Soc., vol. LV, pp. 819-821 (1978).
S.D. Sament et al., "Synthesis and Pharmacology . . . ," J. Indian Chem. Soc., vol. LVI, pp. 1002-1005 (1979).
B.M. Khadilkar et al., "Synthesis and Pharmacology . . . ," J. Indian Chem. Soc., vol. LXIII, pp. 519-521 (1986).
Peter E. Cross, "Substituted Trixluermothly . . . ," Eur. J. Med. Chem, Chimia Therapeutica, vol. 12, pp. 173-176 (1977).
Maria J. Mokrosz, "Structure-activity," Chemical Abstracts, 121:291198x, p. 24 (1994).
Anand Nitya
Bahadurgupta Jang
Jain Sanjay
Mehta Anita
Sinha Neelima
Ambrose Michael G.
Deshmukh Jayadeep R.
Ranbaxy Laboratories Limited
LandOfFree
1-(4-arylpiperazin-1-yl)-.omega.-[n-(.alpha.,.omega.-dicarboximi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1-(4-arylpiperazin-1-yl)-.omega.-[n-(.alpha.,.omega.-dicarboximi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-(4-arylpiperazin-1-yl)-.omega.-[n-(.alpha.,.omega.-dicarboximi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1486816